Peter Sands
Peter Sands is the executive director of the Global Fund for HIV, TB and Malaria, where he advocates for innovative solutions to combat global health issues. A former investment banker, Sands emphasizes the importance of economic arguments in securing funding for health initiatives, particularly in the fight against HIV. He has been instrumental in promoting the roll-out of lenacapavir, a groundbreaking anti-HIV jab, demonstrating his commitment to improving health outcomes in low-income countries.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 6.00 | 0.04% | +0% | 67,886,011 | 28,741 | $2,700,000 | 1,143$ |
| Totals | 1 | 67,886,011 | 28,741 | $2,700,000 | 1,143$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Peter Sands, the executive director of the Global Fund, stated that they are not backing off the ambition to deliver Lenacapivir to two million people if they can.
6
South Africa:
Peter Sands is the executive director of the Global Fund and confirmed plans to proceed with the lenacapavir deal.
6
South Africa:
Peter Sands, the Global Fund executive director, emphasizes the importance of lenacapavir in the fight against HIV.
9